Niagen Bioscience (NAGE) Inventory Average (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Inventory Average data on file, last reported at $22.2 million in Q1 2026.

• On a quarterly basis, Inventory Average rose 118.09% year-over-year to $22.2 million in Q1 2026; TTM through Mar 2026 was $22.2 million, a 118.09% increase from a year earlier, with the FY2025 full-year figure at $14.8 million, up 24.87% from the prior year.
• Inventory Average for Q1 2026 stood at $22.2 million, up from $19.6 million in the prior quarter.
• Over the last five years, Inventory Average for NAGE reached as high as $22.2 million in Q1 2026 and fell as low as $9.9 million in Q4 2024.
• Historically, Inventory Average has averaged $14.1 million across 5 years, with a median of $13.5 million in 2024.
• Across the five-year window, Inventory Average retreated 27.3% in 2024 and soared 118.09% in 2026, its largest moves.
• Year by year, Inventory Average stood at $15.2 million in 2022, then declined by 10.44% to $13.6 million in 2023, then slipped by 27.3% to $9.9 million in 2024, then surged by 98.7% to $19.6 million in 2025, then advanced by 13.32% to $22.2 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $22.2 million in Q1 2026, $19.6 million in Q4 2025, and $16.6 million in Q3 2025.